Intraventricular enzyme delivery for lysosomal storage diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/46 (2006.01)

Patent

CA 2636991

Lysosomal storage diseases can be successfully treated using intraventricular delivery of the enzyme which is etiologically deficient in the disease. The administration can be performed slowly to achieve maximum effect. Surprisingly, effects are seen on both sides of the blood- brain barrier, making this an ideal delivery means for lysosomal storage diseases which affect both brain and visceral organs.

La présente invention concerne des maladies de stockage des lysosomes pouvant être traitées avec succès par une administration intraventriculaire de l~enzyme qui est étiologiquement insuffisante dans la maladie. L~administration peut être effectuée lentement pour obtenir un effet maximal. Il est surprenant de constater que des effets sont visibles sur les deux côtés de la barrière hématoencéphalique, faisant de ce procédé un moyen d~administration idéal pour des maladies de stockage des lysosomes affectant à la fois le cerveau et des organes viscéraux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intraventricular enzyme delivery for lysosomal storage diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intraventricular enzyme delivery for lysosomal storage diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraventricular enzyme delivery for lysosomal storage diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1980062

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.